Encellin

Viacyte

This regenerative medicine company develops stem cell-derived islet replacement therapies for patients living with type 1 diabetes.

Endogenex

This company develops an endoscopic system using pulsed electric fields to treat type 2 diabetes by regenerating signalling cells in the small intestine.

Zucara Therapeutics

This company develops a drug therapy to prevent hypoglycemia in patients with type 1 diabetes using insulin therapy.

Caspian Therapeutics

The company develops small-molecule menin inhibitors to restore insulin production in patients with diabetes and cardiometabolic diseases.

Beta Bionics

This company develops an autonomous insulin delivery system for children and adults living with type 1 diabetes to manage their glucose levels.

DiogenX

This biotech company develops recombinant proteins designed to regenerate insulin-producing pancreatic beta cells for patients with type 1 diabetes.

Sequel Med Tech

This medical device company develops automated insulin delivery systems for patients with type 1 diabetes to improve medication dosing and disease management.

Fractyl Health

This company develops endoscopic procedural therapies and gene therapy platforms to treat patients with obesity and type 2 diabetes.